ArticleLeukemia2017

Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.

W Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.